Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors for Anemia in CKD
- PMID: 34739195
- DOI: 10.1056/NEJMe2117100
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors for Anemia in CKD
Comment on
-
Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis.N Engl J Med. 2021 Dec 16;385(25):2325-2335. doi: 10.1056/NEJMoa2113379. Epub 2021 Nov 5. N Engl J Med. 2021. PMID: 34739194 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical